The official recommendation for omega-3 fatty acids is, to put it politely, deeply conservative. The NIH suggests 1.1–1.6g of ALA (the plant-based omega-3) per day for adults. The American Heart Association recommends "two servings of fatty fish per week." Neither figure reflects what decades of cardiovascular, neurological, and inflammatory research actually suggests as optimal.
So what does the evidence say? And why are most people — including those who think they're eating "healthy" — chronically deficient?
First: The Three Types of Omega-3
Omega-3s are not a single nutrient. There are three distinct fatty acids in the family, and their effects — and your body's ability to use them — differ substantially:
- ALA (alpha-linolenic acid): The plant-based omega-3. Found in flaxseed, walnuts, chia. Your body can technically convert it to EPA and DHA, but does so very inefficiently — most studies show conversion rates of 5–10% to EPA and less than 1% to DHA.
- EPA (eicosapentaenoic acid): The marine omega-3 with strong anti-inflammatory and cardiovascular effects. Found in fatty fish, fish oil, algae oil.
- DHA (docosahexaenoic acid): The structural omega-3. Makes up approximately 40% of the fatty acids in your brain's grey matter and 60% in the retina. Critical for cognitive function, fetal development, and neurological health.
When most researchers talk about optimal omega-3 intake, they're referring to EPA and DHA combined — not ALA. This distinction matters enormously, and it's where most official guidance falls short.
The Omega-3 Index: A Better Metric
One of the most useful tools for understanding omega-3 status isn't a daily gram target — it's the Omega-3 Index, developed by Dr. William Harris and colleagues. It measures EPA+DHA as a percentage of total red blood cell fatty acids and is now considered one of the most robust markers of cardiovascular risk.
| Omega-3 Index | Risk Category | Population Prevalence (US) |
|---|---|---|
| <4% | High cardiovascular risk | ~65% of Americans |
| 4–8% | Intermediate | ~30% of Americans |
| >8% | Optimal, low risk | ~5% of Americans |
The average American has an Omega-3 Index of approximately 4–5%. In Japan — where fatty fish consumption is among the highest in the world — the average is 8–11%. This gap is believed to contribute meaningfully to the well-documented differences in cardiovascular outcomes between the two populations.
Reaching an index above 8% typically requires either:
- Consistent fatty fish consumption 3–5x per week, or
- Supplementation with 2–3g EPA+DHA daily
What the Large Trials Show
The omega-3 research landscape includes some of the largest cardiovascular trials ever conducted. The conclusions are nuanced and sometimes contradictory — partly because study populations, dosages, and endpoints vary significantly.
PREDIMED (2013)
This landmark Spanish trial randomised 7,447 people at high cardiovascular risk to either a Mediterranean diet supplemented with olive oil, a Mediterranean diet supplemented with nuts, or a low-fat control diet. Fatty fish consumption (a key component of the Mediterranean arm) was associated with a 30% relative reduction in major cardiovascular events. Dietary omega-3 intake, not supplementation, was the primary vehicle.
VITAL (2019)
Over 25,000 participants, 5 years, 1g EPA+DHA daily. The headline finding was no significant reduction in major cardiovascular events overall — but there was a 28% reduction in heart attacks specifically, and subgroup analyses suggested stronger effects in people who consumed little fish at baseline.
REDUCE-IT (2018)
This is where things get more striking. High-dose icosapentaenoic acid (EPA only, as Vascepa) at 4g per day reduced major adverse cardiovascular events by 25% in patients with elevated triglycerides, despite receiving statin therapy. The absolute risk reduction was clinically meaningful.
The REDUCE-IT results helped shift expert opinion toward higher-dose EPA being meaningfully cardioprotective — and raised the question of whether the 1g doses used in earlier trials were simply too low to show effect.
Dosage Recommendations: A Practical Framework
Given the evidence, here's a reasonable framework for thinking about omega-3 intake:
| Goal | EPA+DHA Daily Target | Dietary Equivalent |
|---|---|---|
| General population baseline | 500mg–1g | 1–2 servings fatty fish/week |
| Achieve Omega-3 Index >8% | 2–3g | 3–5 servings fatty fish/week or supplement |
| Cardiovascular disease, high TG | 3–4g (under medical supervision) | Prescription or high-dose supplement |
| Pregnancy / breastfeeding | 300–900mg DHA (per ACOG/WHO guidance) | 2–3 servings low-mercury fish/week |
The Best Food Sources
If you'd rather get your omega-3s from food — which most researchers consider preferable to supplements, for reasons related to food matrix effects and co-occurring nutrients — the richest sources are:
| Food (100g serving) | EPA+DHA (approx) | Notes |
|---|---|---|
| Sardines (canned in water) | 1,500–2,000mg | Excellent EPA/DHA ratio, low mercury, sustainable |
| Wild salmon | 1,500–2,500mg | Higher in DHA; astaxanthin adds antioxidant benefit |
| Mackerel | 2,000–2,500mg | Very high omega-3, low price — underrated |
| Herring | 1,500–2,000mg | Atlantic herring is among the most sustainable choices |
| Anchovies | 1,200–1,500mg | Typically canned; concentrated flavour allows small portions |
| Farmed Atlantic salmon | 2,000–3,000mg | Often higher than wild; omega-3 content depends on feed |
| Oysters | 500–700mg | Good DHA source; also high in zinc |
| Algae oil (supplement) | Variable (400–600mg DHA) | Best vegan option; direct DHA, no conversion needed |
Why Supplements Often Underperform
Omega-3 supplements are a $4+ billion annual market. Yet many people report taking fish oil for years without perceiving benefit — and the clinical literature on supplementation is more mixed than headlines suggest.
Several factors explain this:
- Oxidation: Fish oil oxidises quickly once the capsule is broken. Studies have found that a significant percentage of retail fish oil supplements are oxidised beyond acceptable limits, which may reduce efficacy and potentially cause harm.
- Form matters: Triglyceride-form fish oil is better absorbed than ethyl ester form (which is cheaper to manufacture and more common in budget supplements). Phospholipid forms (krill oil, salmon roe) may be better still, though evidence is still accumulating.
- Dose: Many popular fish oil capsules contain 300–500mg EPA+DHA. To reach 2g/day, you'd need 4–7 capsules — most people take one.
- Baseline matters: People with very low baseline omega-3 status benefit most from supplementation. If you already eat fatty fish regularly, the marginal benefit of adding supplements is smaller.
The Bottom Line
The "two servings of fish per week" recommendation is a floor, not a ceiling. For most people, achieving an Omega-3 Index above 8% — the level associated with lowest cardiovascular risk — requires more consistent intake than typical Western dietary patterns provide.
The most practical, evidence-supported approach:
- Eat fatty fish (sardines, mackerel, salmon, herring) 3–5 times per week
- If you can't reliably do that, supplement with 2g EPA+DHA daily in triglyceride form
- Avoid cheap, bulk fish oil — oxidised omega-3 is at best useless, at worst counterproductive
- Consider getting your Omega-3 Index tested (available through several at-home kits) to know your baseline
For a complete, obsessive breakdown of the food with the best omega-3 profile per calorie — along with mercury data, sustainability, and 30 ways to actually enjoy eating it — see The Obsessive's Guide to Sardines.